Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessing the cost-effectiveness of pharmacogenomics.

AAPS pharmSci - 1 Jan 2000

Veenstra D L, Higashi M K, Phillips K A

Abstract excerpt

The use of pharmacogenomics to individualize drug therapy offers the potential to improve drug effectiveness, reduce adverse side effects, and provide cost-effective pharmaceutical care. However, the combinations of disease, drug, and genetic test characteristics that will provide clinically useful and economically feasible therapeutic interventions have not been clearly elucidated. The purpose of this paper was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Warfarin
Share to Anticholesteremic Agents
Share to Antimetabolites, Antineoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol Ester Transfer Proteins

Share to Cost-Benefit Analysis

Share to Drug Therapy

Share to Mercaptopurine

Share to Pravastatin

Source

Open in PubMed Open full text

Identifiers

PMID: 11741245
DOI: 10.1208/ps020329
PMCID: PMC2761139

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessing the cost-effectiveness of pharmacogenomics.PMID 11741245Read ↗

The Economics of Pharmacogenomics.Semantic proximity Read ↗

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?Semantic proximity Read ↗

Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.Semantic proximity Read ↗

Economic evaluation of pharmacogenetic tests.Semantic proximity Read ↗

Pharmacogenetics and cost-effectiveness analysis: a two-way street.Semantic proximity Read ↗

Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.Semantic proximity Read ↗

Pharmacogenomic testing: the cost factor.Semantic proximity Read ↗

Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care.Semantic proximity Read ↗

Managed care in the genomics era: assessing the cost effectiveness of genetic tests.Semantic proximity Read ↗

Real-world Clinical Effectiveness, Regulatory Transparency and Payer Coverage: Three Ingredients for Translating Pharmacogenomics into Clinical PracticeSemantic proximity Read ↗

Pharmacogenetic screening and therapeutic drugs.Semantic proximity Read ↗

Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.